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Abstract
Epicardial-derived signals are key regulators of cardiac embryonic development. An important part of
these signals is known to relate to a retinoic acid (RA) receptor-dependent mechanism. RA is a potent
morphogen synthesised by Raldh enzymes, Raldh2 being the predominant one in mesodermal tissues.
Despite the importance of epicardial retinoid signalling in the heart, the molecular mechanisms
controlling cardiac Raldh2 transcription remain unknown. In the current study, we show that Wt1-null
epicardial cells display decreased expression of Raldh2 both in vivo and in vitro. Using a RA-responsive
reporter, we have confirmed that Wt1-null epicardial cells actually show reduced synthesis of RA. We
also demonstrate that Raldh2 is a direct transcriptional target of Wt1 in epicardial cells. A secondary
objective of this study was to identify the status of RA-related receptors previously reported to be
critical to epicardial biology (PDGFRα,β; RXRα). PDGFRα and PDGFRβ mRNA and protein levels are
downregulated in the absence of Wt1, but only Pdgfra expression is rescued by the addition of RA to
Wt1-null epicardial cells. RXRα mRNA levels are not affected in Wt1-null epicardial cells. Taken
together, our results indicate that Wt1 critically regulates epicardial RA signalling via direct activation
of the Raldh2 gene, and identify a role for Wt1 in the regulation of morphogen receptors involved in the
proliferation, migration, and differentiation of epicardial and epicardially-derived cells (EPDC).
Keywords: Mouse embryo, Wilms' tumour suppressor gene, Retinoic acid, Raldh2, Epicardium
INTRODUCTION
Retinoic acid (RA) regulates a variety of crucial events during early embryonic development, acting in a
specific organ-dependent manner to control the differentiation of many cell types (Duester, 2008;
Bayha et al., 2009). Retinaldehyde dehydrogenases (RALDHs) are essential enzymes for RA synthesis
in the developing embryo, with Raldh2 being the most broadly expressed dehydrogenase in
mesodermal tissues (Niederreither et al., 1997; Niederreither et al., 2002; Moss et al., 1998).
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Heart development is dramatically affected by RA deficiency, including anomalies in the compaction of
ventricular myocardium (Wessels and Pérez-Pomares, 2004) and abnormal septation (Sinning, 1998).
Availability of RA during cardiac development is mediated by Raldh2 expression. This is first defined by
a rostrocaudal wave at the anterior lateral mesoderm, followed by a secondary wave that progresses
from the cardiac inflow towards the ventricular and conotruncal myocardium, and a final one confined
to the epicardium, the outermost tissue layer of the heart (Xavier-Neto et al., 2000; Niederreither et al.,
2001; Hochgreb et al., 2003). Not surprisingly, Raldh2  embryos display early and lethal defects in
cardiac development (Niederreither et al., 2001).
The epicardium and epicardially derived cells (EPDC) are pivotal to coronary vascular development
(Pérez-Pomares et al., 1998; Pérez-Pomares et al., 2002; Dettman et al., 1998; Landerholm et al., 1999;
Tomanek et al., 2001; Tomanek et al., 2008). However, there is not much known about the nature of
the RA-dependent signals responsible for epicardial and EPDC proliferation, differentiation and
involvement in myocardial growth (Kang and Sucov, 2005; Lavine et al., 2005; Merki et al., 2005).
Epicardial and EPDC express the protein encoded by the Wilms' tumour suppressor gene, Wt1 (Moore
et al., 1999; Pérez-Pomares et al., 2002). Wt1-null mice die at midgestation with defects in the
formation of several organs (Kreidberg et al., 1993), including a characteristic thinning of the
myocardium reminiscent to that exhibited by RA receptor (Rxra) mutant mice (Kastner et al., 1994;
Sucov et al., 1994). As myocardial cells do not express Wt1, this cardiac muscle phenotype is accepted to
be dependent on Wt1-regulated epicardial paracrine signals (Moore et al., 1999; Chen et al., 2002).
Further research on Wt1-null embryos has shown that coelomic cells lining the liver also display a
decreased Raldh2 expression concomitant with liver hypoplasia (IJpenberg et al., 2007).
As Wt1 and Raldh2 expression patterns overlap in space and time, we have analysed RA expression in
Wt1-null mice, and identified Wt1 as a direct regulator of Raldh2 transcription during epicardial
development. Secondary to these findings, we suggest a role for Wt1 in the regulation of RA-related
morphogen receptors essential to epicardial and EPDC biology.
MATERIALS AND METHODS
The animals used in our research program were handled in compliance with the international
guidelines for animal care and welfare. Wt1-null, yWT470LacZ (Wt1-LacZ) and Wt1-GFP mouse lines
were generated as previously described (Kreidberg et al., 1993; Moore et al., 1999; Hosen et al., 2007).
Histology and immunohistochemistry
Single Raldh2, CD31 and Wt1 immunofluorescence and immunoperoxidase on 10 μM sections and
cultured cells, as well as Wt1-lacZ embryo processing were performed as described elsewhere
(IJpenberg et al., 2007). Double immunohistochemistry involving Wt1 was carried out as previously
described (Pérez-Pomares et al., 2002) using anti-PDGFRα, anti-PDGFRβ and anti-RXRα antibodies
(eBioscience 14-1401-81; Sc-432; Sc-553, respectively). A non-specific rabbit IgG was used instead of
the primary antibodies for negative controls.
Immortalised epicardial cell lines (MEEC)
Hearts from control (Wt1 ) and Wt1-null mice (Wt1 ) carrying the ‘immorto’ transgene (Jat
et al., 1991) were isolated at E11.5 and cultured on 24-well gelatinised dishes containing DMEM. After
24 hours, hearts were removed and epicardial cells attached to the surface were cultured and
propagated as described previously Martínez-Estrada et al. (Martínez-Estrada et al., 2010). Treatments
with retinoic acid (all-trans, Sigma) were performed at 1 μM concentration (24 hours). Control for the
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treatments was incubation with the RA vehicle (ethanol 100°, 1:1000).
Western blotting
Western blots were performed as described previously (Martínez-Estrada et al., 2010).
Luciferase and RA reporter assays
The Raldh2 upstream region (830 bp) was amplified by PCR from mouse genomic DNA and cloned
into the pGL4.10 vector (Promega). Primer sequences were: forward, 5′-
AAAGCTAGCTCTCCCACGCTATCTGGAGT-3′; reverse, 5′-AAAAGATCTGATCTCGCTGGAAGTCATGG-
3′. PCR product was digested with NheI and BglII and cloned into the corresponding sites upstream of
the firefly luciferase construct in the pGL4.10 vector.
This reporter construct (100 ng) was transfected in immortalised epicardial cells, in the presence of the
indicated amounts of expression construct encoding −KTS Wt1 isoform (Martinez-Estrada et al., 2010).
Site-directed Raldh2 promoter mutagenesis assays
Site-directed mutagenesis was performed with the QuikChange II XL kit (Stratagene), following the
manufacturer's instructions. The oligonucleotides and their reverse-complementary sequences used
were: Mut1, 5′-CTGGGCCGGCCCCCAAAGCCTGTGGGCC-3′; Mut2, 5′-
AAGAAGCGAAACCCGCTTGACACCTGCC-3′; Mut3, 5′-ACAGCGAGCGAAACCCGGCCGCGCAGCG-3′.
All mutations were verified by sequencing.
ChIP assay
Chromatin immunoprecipitation (ChIP) assays were performed on immortalised epicardial cells
(Martínez-Estrada et al., 2010) using an EZchIP (Upstate Biotechnology) according to the
manufacturer's protocols. The primer sequences used were: positive forward,
GCTGGAAGGAGACCATCAAGAC; positive reverse, GAGCCTTAGCGCTGGTGGGCCG; negative forward,
AGCTACCTCCCCACCATTCT; and negative reverse: GCCTAAAGTGACCGAGCAAG.
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay was performed using biotin 3′-end labelled 21 bp probes for the
three Wt1 putative-binding sites identified in Fig. 2F′ on MEEC nuclear extracts. Probes were incubated
with 6 μg of nuclear protein extracts for 20 minutes at room temperature. The remaining steps follow
the LightShift Chemiluminescent EMSA Kit protocol (Pierce).
RNA extraction and semi-quantitative PCR
Total RNA from immortalised epicardial cells was extracted using RNeasy Mini Kit (Qiagen) and
reverse-transcripted using oligo dT18 (First Strand cDNA Synthesis Kit/AMV, ROCHE). β-Actin was
amplified as reference gene.
Quantitative PCR
Real-time quantitative PCR reactions were performed in an ABI7500 (Applied Biosystems, Carlsbad,
CA, USA) and carried out using specific TaqMan Gene Expression Assays, using Eukaryotic 18s rRNA
(reference 4319413E from Applied Biosystems) as a reference gene.
Data analysis involved a relative quantification with 2  method [modified from Yuan et al. (Yuan et
al., 2006)]; included 2  Std Err values between 1-8.5%, followed by an unpaired t-test with n≥3
−ΔCq
−ΔCq
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(P<0.05).
For qPCR of FACS-sorted GFP  epicardial cells, hearts of Wt1  and Wt1  mice were dissected
and the ventricles trypsinised for 15 minutes at 37°C in a temperature controlled shaker at 1000 rpm.
Analysis of gene expression was carried out by Taqman real-time PCR (Roche) using Gapdh as
reference gene. qPCR on embryonic epicardial immortalised cells was performed using the following
references from Applied Biosystems: RXRα, Mm00441182_m1; PDGFRβ, Mm01262489_m1; PDGFRα,
Mm01211694_m1.
RESULTS AND DISCUSSION
To investigate whether Wt1 plays a role in the regulation of Raldh2 expression in the embryonic
epicardium, we analysed Raldh2 protein expression in the heart of Wt1-null embryos. The
epicardium/EPDC of Wt1-null mice express other epicardial markers normally (cytokeratin, Fig. 1A,B),
but display a clear decrease in Raldh2 protein (compare Fig. 1C,E with 1D,F). Strikingly, Raldh2 protein
expression in Wt1-null atrial epicardium is not as affected as in the ventricles. This singular feature of
the Wt1-null cardiac phenotype could depend on the impact of different segment-specific signalling
properties of the embryonic myocardium (Mjaatvedt et al., 1987) in the epicardial transcriptome, rather
than on chamber-related intrinsic/autonomous epicardial programs. This hypothesis is partially
supported by the loss of cardiac inflow epicardial Raldh2 expression in Wt1-mutant mice (Norden et al.,
2010). By using the Wt1 GFP KI mice (Hosen et al., 2007), we have been able to select GFP  epicardial
cells in control and KO mice. qPCR analysis of FACS-sorted GFP  epicardial cells confirmed the lack of
Wt1 expression in Wt1-null cells (see Fig. S1 in the supplementary material) and indicated a clear
downregulation of Raldh2 levels in the mutant epicardium (Fig. 1G). These first results, together with
Wt1/Raldh2 protein overlapping spatiotemporal patterns, set the main and primary objective of our
study, i.e. to examine whether Raldh2 embryonic epicardial expression is regulated by Wt1.
To initiate a molecular analysis of Wt1-Raldh2 relationship, we generated Wt1 KO immortalised
epicardial cells. FACS analysis demonstrated GFP expression in control and Wt1 KO epicardial cells
(data not shown), while western blot analysis showed Wt1 expression only in control cells (Fig. 2A). We
also checked Raldh2 expression using semi-qPCR (Fig. 2B) and qPCR (Fig. 2C) in both control and
Wt1-null immortalised epicardial cells, and found similar levels of downregulation as in the vivo
epicardium. A RA-luciferase responsive reporter assay showed a significantly lower signal in mutant
immortalised epicardial cells (Fig. 2D), indicating that Raldh2 downregulation in absence of Wt1
expression involves an actual reduction of RA synthesis.
Despite the importance of RA/Raldh2 in epicardium and heart development, very little is known about
the transcriptional regulation of epicardial Raldh2. The strong reduction of Raldh2 mRNA levels in
both freshly isolated and cultured Wt1 KO epicardial cells prompted us to analyse whether Wt1 could
be a direct transcriptional regulator of the Raldh2 gene. We identified three putative conserved Wt1-
binding sites in the Raldh2 promoter that were confirmed to interact in vitro with Wt1 protein by using
an EMSA (see Figs S2 and S3 in the supplementary material). The −KTS Wt1 isoform was able to
activate the Raldh2 promoter fragment containing the putative binding sites in a dose-dependent
manner (Fig. 2E). Then, we generated a series of reporter constructs that carried individual, double or
triple mutations in the binding sites (Fig. 2F′). Constructs with a single mutation (M1, M2 or M3)
became less sensitive to −KTS Wt1 activation when compared with the control group. Double mutation
(M1-2; M1-3) reduced Wt1 activation by 70%; similar results were obtained for the triple mutant (M1-
2-3) (Fig. 2F). Thus, Raldh2 is activated via Wt1 sites in its promoter. Chromatin-IP (Fig. 2G)
confirmed binding of Wt1 to the endogenous Raldh2 promoter in epicardial cells.
+ GFP/+ GFP/−
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RA activity has multiple effects on a variety of signalling pathways. As we have shown that Wt1-null
epicardial RA levels are significantly reduced, a secondary objective of our study was to evaluate
whether this RA decrease actually affected RA-related receptors known to be important for epicardial
and EPDC development such as RXRα, PDGFRα and PDGFRβ. Wt1, which is expressed in all
epicardial and EPDC during the first days of epicardial embryonic development (Fig. 3A-C), colocalises
with these three receptors in the epicardium and EPDC (Fig. 3D-F). In vivo mRNA expression of these
molecules in Wt1 -sorted E11.5 epicardial cells was confirmed by qPCR (see Fig. 4).
RXRα is expressed in epicardial cells and its signalling is crucial to epicardial and myocardial
development (Chen et al., 1998; Chen et al., 2002; Merki et al., 2005). This, together with the
similarities reported for the cardiac phenotype of the Wt1-null and the Rxra-null mouse embryos
(Kreidberg et al., 1993; Kastner et al., 1994), led us to study RXRα epicardial expression in Wt1-null
embryos. RXRα-positive epicardial cells are infrequent in control and Wt1-null embryos (E11.5).
Immunohistochemistry did not record any significant changes between these two groups at this
developmental stage (Fig. 4A,B). This was further confirmed by qPCR on E11.5 control and Wt1-
deficient epicardial immortalised cells (Fig. 4N). However, the number of RXRα-positive cells in the
epicardium/EPDC of Wt1-null embryos, when compared with stage-matched controls, is reduced at
later stages (E13.5) (Fig. 4C,D). This could relate to the defective epicardial epithelial-mesenchymal
transition of Wt1 mutants (Moore et al., 1999; Martínez-Estrada et al., 2010). Interestingly, epicardial
cells also express Rara, although at lower levels in control than in Wt1-null epicardial cells (see Fig. S4
in the supplementary material). This finding is in accordance with the previously reported active
inhibition of RARα by Wt1 (Goodyer et al., 1995).
PDGF signalling through PDGF receptors α and β, both expressed in the epicardium (Lu et al., 2001;
Guadix et al., 2006), is known to be important for epicardial/EPDC proliferation and migration (Kang
et al., 2008; Mellgren et al., 2008). We found a much reduced immunoreactivity for PDGFRα (
Fig. 4E,F) and PDGFRβ receptors in E11.5 (Fig. 4G,H) and E13.5 (Fig. 4I,J) Wt1-null embryos. qPCR
in control (Wt1 ) and Wt1-null (Wt1 ) sorted E11.5 epicardial cells also revealed a significant
reduction in the expression of Pdgfra and Pdgfrb in mutant versus control cells (Fig. 4L). qPCR
analysis on control and Wt1-null epicardial immortalised cells confirmed these results for Pdgfra (
Fig. 4N). However, Pdgfrb levels in Wt1-null epicardial immortalised cells seemed to be extremely
variable, and therefore immortalised Wt1-null cells were not used as a model to study the
transcriptional activity of this specific gene. Remarkably, the low expression levels of Pdgfra in Wt1-
null immortalised epicardial cells could be partially rescued by RA treatment (Fig. 4N). Such
stimulation of the expression of Pdgf/Pdgfr by RA, inducing cell proliferation, has been reported in
other systems (Tsukamoto et al., 1994; Liebeskind et al., 2000), thus suggesting that Wt1 function in
the regulation of Pdgfra is mediated in part by RA signalling. More extensive analysis will be required
to delineate the molecular mechanisms underlying Pdgfra and Pdgfrb downregulation in Wt1-null
epicardium.
In summary, the connection between Wt1 and RA suggested by our results provides new and crucial
information on the regulation of epicardial development, opening new avenues on the research of the
cell-autonomous and non-autonomous functions of Wt1 during cardiac embryogenesis.
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Figures and Tables
Fig. 1.
Wt1 deletion is associated with downregulation of Raldh2 expression in the epicardium. (A,B) Cytokeratin
(CK) immunoreactivity in the left ventricle (LV) of E11.5 control (A) and Wt1-null (B) mouse embryos. The epicardium
(Ep) is discontinuous in mutant embryos, but present epicardial cells normally express CK (arrows in B). (C,D) Raldh2
immunoreactivity is conspicuous in wild-type ventricular (V) epicardium (Ep) and epicardially derived cells (C,
arrowheads), but clearly reduced in Wt1-null mice (D, arrowheads). The thickness of compact ventricular myocardium is
reduced in Wt1-null mice (C,D, double-headed arrows). (E,F). Raldh2 expression in the atrioventricular (A, atrium; V,
ventricle) region of wild-type (E) and Wt1-null (F) mice. Atrial immunoreactivity is not significantly reduced (E,F,
arrows) when compared with the decay of protein levels in the ventricles of Wt1-null mice (arrowheads). (G) Raldh2
qPCR in control and Wt1-null GFP-sorted E11.5 epicardial cells (*P<0.05, 10 d.o.f.). Data are mean+s.e.m.
Fig. 2.
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Wt1 is an activator of Raldh2 in epicardial cells.(A) Wt1 western blot in control and Wt1-null immortalised
epicardial cells. (B,C) Raldh2 semi-qPCR (B) and qPCR (C) in control and Wt1-null immortalised epicardial cells. (D)
RA-luciferase responsive reporter activity assay in control and Wt1-null immortalised epicardial cells. (E) The −KTS Wt1
isoform activates a Raldh2 promoter fragment containing the putative binding sites in a dose-dependent manner. (F,F′)
Raldh2 promoter-luciferase mutagenesis assay. Reporter constructs, carrying single, double or triple mutations (see the
schematic representation of the putative conserved Wt1-binding sites in the Raldh2 promoter, F′) were transiently co-
transfected into epicardial cells with −KTS Wt1 expression vector. (G) ChIP assay in control and Wt1-null immortalised
epicardial cells. Binding of Wt1 protein to the Raldh2 promoter is amplified with primers for Wt1 putative binding sites
to Raldh2 promoter (1) or primers for regions upstream these sites (2). All asterisks indicate statistical significance
(*P<0.05, 10 d.o.f.). Data are mean+s.e.m.
Fig. 3.
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Mouse embryonic epicardial cells express RA-related receptors. (A,B) E11.5 Wt1-lacZ mouse heart. At this
stage, all epicardial and epicardially derived cells express Wt1, as shown by the reporter activity (blue). (C) Wt1 protein
expression in E11 epicardium is confirmed by immunohistochemistry. Protein colocalisation of Wt1 with RXRα, PDGFRα
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and PDGFRβ is illustrated in D-F. Abbreviations: A, atrium; AVC, atrioventricular canal/cushions; Ep, epicardium;
EPDCs, epicardially derived cells; LV, left ventricle; RV, right ventricle.
Fig. 4.
Status of RA-related receptors in Wt1-null epicardial cells. (A-D) RXRα immunoreactivity in E11.5 wild-type
(A) and Wt1-null (B) embryonic epicardium is not significantly different (arrowheads); differences in RXRα epicardial
immunoreactivity in E13.5 wild-type (C) and Wt1-null (D) embryos are evident (arrows). (E,F) PDGFRα
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immunoreactivity in the ventricular epicardium of E11.5 Wt1-null embryos (F, arrowheads) is reduced when compared
with stage-matched wild types (E, arrowheads). (G-J) PDGFRβ immunoreactivity is reduced in the ventricular (H,
arrowhead) but not atrial epicardium (H, arrow) of E11.5 and E13.5 Wt1-null embryos (J, arrow) when compared with
E11.5 (G, arrowheads) and E13.5 (I, arrow) wild types. The Wt1-negative cells of endocardial cushions are PDGFRβ
positive (J, arrowhead). (K) Procedure for the characterisation of embryonic epicardial cells. Wt1  and Wt1
hearts were dissected, GFP-positive epicardial cells sorted, mRNA extracted and analysed by qPCR (L). (M) Procedure
for the isolation and qPCR analysis of control (Wt1 ) and Wt1-null (Wt1 ) immortalised epicardial cells. (N)
qPCR analysis of Rxra, Pdgfra. RA treatment (1 μM RA for 24 hours) of mutant cells did not affect Rxra levels but did
increase Pdgfra levels in Wt1-null cells. All asterisks indicate statistical significance (P<0.05, 10 d.o.f.). Data are
mean+s.e.m. Abbreviations: A, atrium; Ep, epicardium; V, ventricle.
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